Compare APPS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPS | CERT |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Retail: Computer Software & Peripheral Equipment |
| Sector | Miscellaneous | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2012 | 2020 |
| Metric | APPS | CERT |
|---|---|---|
| Price | $11.80 | $7.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $6.25 | ★ $11.67 |
| AVG Volume (30 Days) | ★ 2.4M | 2.1M |
| Earning Date | 06-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.92 | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | $103,569,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $15.60 | $4.18 |
| Revenue Next Year | $11.34 | $5.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.55 | 8.75 |
| 52 Week Low | $2.74 | $4.45 |
| 52 Week High | $15.34 | $13.88 |
| Indicator | APPS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 56.13 | 38.50 |
| Support Level | $8.03 | $6.48 |
| Resistance Level | $11.71 | $7.44 |
| Average True Range (ATR) | 0.63 | 0.30 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 96.00 | 4.93 |
Digital Turbine Inc is an independent mobile growth platform that levels up the landscape for advertisers, publishers, carriers, and device original equipment manufacturers. The Company offers end-to-end products and solutions leveraging proprietary technology to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. In addition, its products and solutions provide monetization opportunities for OEMs, carriers, and application (app or apps) publishers and developers.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.